(19)
(11) EP 0 915 969 A1

(12)

(43) Date of publication:
19.05.1999 Bulletin 1999/20

(21) Application number: 97917856.0

(22) Date of filing: 02.04.1997
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61K 38/ 00( . )
A61K 39/ 395( . )
A61K 47/ 48( . )
A61P 31/ 18( . )
C07K 14/ 47( . )
C07K 16/ 00( . )
C12N 5/ 06( . )
A61K 31/ 00( . )
A61K 38/ 19( . )
A61K 45/ 00( . )
A61P 31/ 00( . )
C07K 7/ 00( . )
C07K 14/ 715( . )
C07K 16/ 28( . )
(86) International application number:
PCT/US1997/005597
(87) International publication number:
WO 1997/037005 (09.10.1997 Gazette 1997/43)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 02.04.1996 US 19960627684
14.06.1996 US 19960663616
25.06.1996 US 19960673682

(71) Applicant: PROGENICS PHARMACEUTICALS, INC.
Tarrytown, NY 10591 (US)

(72) Inventors:
  • ALLAWAY, Graham, P.
    Westminster, MD 21157-6231 (US)
  • LITWIN, Virginia, M.
    Syracuse, NY 13206 (US)
  • MADDON, Paul, J.
    New York, NY 10032 (US)
  • OLSON, William, C.
    Tarrytown, NY 10591 (US)

(74) Representative: VOSSIUS & PARTNER 
Postfach 86 07 67
81634 München
81634 München (DE)

   


(54) METHOD FOR PREVENTING HIV-1 INFECTION OF CD4+ CELLS